Bioforum will bring the real-world data solutions of Clinerion’s Patient Network Explorer platform to patients and physicians in Israel and Australia, accelerating the development of innovative medications and improving access to new treatments.
Bioforum is a data-focused Contract Research Organization (CRO), offering a wide range of consulting services, including medical writing, data management and bio-statistical support.
Bioforum will support Clinerion by leveraging its network to enlarge Clinerion’s outreach in Bioforum’s target markets of Israel and Australia. Bioforum will also identify potential customers for Clinerion’s services, which enable pharmaceutical trial sponsors to more accurately refine trial protocol criteria and then find and match their trials to sites and patients, accelerating the set-up phase of trials by months.
“We are extremely excited to launch this collaboration and are confident that together we can promote clinical research in our target markets. We are keen to introduce more medical centers to Clinerion’s advanced technology,” says Bioforum’s President & Co-Founder, Mr. Amir Malka.
“Patients in both Israel and Australia are underserved by clinical research at the moment,” says Ian Rentsch, CEO of Clinerion. “We are pleased to have Bioforum on board to support bringing our solutions to market.”
For more information go to www.clinerion.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.